The Fedtrade® podcast recently interviewed Lisa Pettigrew, CEO and Founder of CRO Syndicate, as part of our SelectUSA Investment Summit Spotlight series. CRO Syndicate provides seasoned interim executives to exponentially grow your company’s revenue through strategic, collaborative, and pragmatic real-world solutions. Representatives from CRO Syndicate will be attending the 2025 SelectUSA Investment Summit in National
Dans un précédent post, nous nous sommes penchées sur la définition de l’intelligence artificielle pour souligner que quelle que soit sa finalité, générative, prédictive ou autre, l’IA a besoin de se nourrir d’une quantité énorme de données. Lorsque ces données sont des œuvres protégées par le droit d’auteur, se pose la question de savoir
New Mountain Capital has completed a strategic investment in SmarterDx, according to a news release.
SmarterDx, founded in 2020 and based in New York, develops clinical artificial intelligence focused on revenue integrity and care quality.
New Mountain, based in New York, is a growth-oriented investment firm. Founded in 1999, the firm manages private
The current EU regulatory landscape for biotechnology is widely viewed as insufficient to be able to exploit the full potential of such technologies. Regulatory hurdles exist at EU and Member State level, and this is thought to have driven investment into other regions.
To help tackle this problem, the introduction of a new EU Biotech
Welcome to the latest installment of Arnold & Porter’s Virtual and Digital Health Digest. This digest covers key virtual and digital health regulatory and public policy developments during March and early April 2025 from the United States, United Kingdom, and European Union.
The biggest change this month is that as of March 25, 2025, the
On April 4, 2025, the Centers for Medicare & Medicaid Services (“CMS”) released the contract year (“CY”) 2026 final rule for the Medicare Advantage (“MA”) program, Medicare Prescription Drug Benefit Program (“Part D”), Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (the “Final Rule”). While CMS finalized several proposals
A recent Patent Trial and Appeal Board decision related to hybrid quantum computing paves the way for more quantum computing-related patents, and potential litigation.
Quantum computing is an important and evolving form of computing that has yet to be truly realized. Classical computing is, fundamentally, governed by the ability to store information in a
On Monday, March 31, a court in the Eastern District of Texas found unlawful and vacated the Food and Drug Administration’s 2024 Rule regulating as “devices” under the Food, Drug, and Cosmetic Act (“FDCA”), certain laboratory-developed test (“LDTs”) used to diagnose, monitor, or determine treatment for diseases and conditions. The decision, American Clinical Laboratory Assoc. v.
The European Data Protection Body (EDPB) has published a study on how personal health data is and/or can be reused for scientific research in the EU under the EU General Data Protection Regulation (GDPR). The study highlights the related practical challenges due to divergent interpretations of the GDPR and national rules across EU Member States.
The Fedtrade® podcast recently interviewed Daniel Clark, Vice President and Director of Business Development at the New York City Economic Development Corporation (NYCEDC), as part of our SelectUSA Investment Summit Spotlight series. NYCEDC is a mission-driven, nonprofit organization that works for a vibrant, inclusive, and globally competitive economy for all New Yorkers. They take a